Journal scan

Pimavanserin provides short-term benefit in Alzheimer’s disease psychosis

A study suggests that pimavanserin may be safer than traditional antipsychotic medications for people with Alzheimer’s disease
Posted 16 October 2018 - 09:18
 
Jobs

Related articles
Free

Worrying rise in pertussis cases across UK and Europe

Nurses should advise parents and pregnant women to book a vaccination appointment
16 Apr 2024

Patient and public involvement in doctoral research involving people living with...

Involving people with conditions such as dementia in research is vital to its quality and...
27 Mar 2024

Delirium superimposed on dementia: mental health nurses’ experiences of providing care

Knowing patients cannot be reduced to a numerical tool and an integrated approach is needed
26 Mar 2024

Risk management and decision-making in dementia care

Encouraging a proactive and person-centred approach to risk assessment and management
20 Mar 2024
5 Most Read Articles

Can difficult personal circumstances excuse mistakes at work?

We ask our readers if factors outside of work should be considered relevant
26 Mar 2024

Advanced nursing practice: is it under attack and why?

The role is often misunderstood – as highlighted in the debate over physician associates
15 Apr 2024

The (quiet) steps you can take to help inpatients get a good night’s sleep

Find out about measures that minimise disturbance at night – but don’t mean extra workload
01 Apr 2024

Work-life balance: what I’ve gained in an occupational health role

It can offer more flexibility than ward or community jobs. Find out what’s involved
18 Apr 2024

From NHS nurse to lecturer: making the transition to education

What I’ve learned moving from an NHS role to academia, and the skills you need
11 Apr 2024
Journals
Other RCNi websites